cancel1

Delaware Supreme Court upholds Fresenius/Akorn decision

Delaware’s highest state court has confirmed that healthcare company Fresenius was entitled to pull out of its multibillion-dollar acquisition of Akorn after finding that the generic drugmaker had misrepresented the state of its data.

Gain full access to
Global Data Review

The one-stop information source and community touchpoint, with coverage from across the areas of data protection, cybersecurity, IP, IT and TMT.

OR